SYRE logo
Spyre Therapeutics, Inc.(SYRE)
Last print unknown agoAbout this dataData status
$84.72▲4.82 (6.03%)Stale · unknown oldEarnings · Nov 3

SYRE Total Assets

$1.17BQuarterly · USD

Period ending:

SYRE FY Total AssetsUSD
SYRE FY Total Assets2013-12-31: $4.60M2014-12-31: $2.93M2015-12-31: $38.65M2016-12-31: $67.06M2017-12-31: $56.08M2018-12-31: $77.74M2019-12-31: $83.18M2020-12-31: $161.62M2021-12-31: $109.93M2022-12-31: $71.14M2023-12-31: $341.86M2024-12-31: $608.48M2025-12-31: $777.78M$777.78M$0.00
2013-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

SYRE total assets history

Total value of everything the company owns. The available annual fiscal periods series contains 13 observations from Dec 31, 2013 to Dec 31, 2025.

Spyre Therapeutics Inc Total Assets — Annual fiscal periods (USD)
Period endingTotal Assets (USD)
777,781,000
608,484,000
341,859,000
71,144,000
109,926,000
161,618,000
83,183,000
77,739,000
56,077,000
67,063,000
38,654,000
2,930,000
4,597,000

Compare total assets

All SYRE financial metrics · SYRE stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.